Sun Pharma, Cipla recall products in US over manufacturing issues: USFDA

Sun Pharma and Cipla, two leading drug manufacturers from India, are taking precautionary measures by recalling products in the United States due to safety concerns. Sun Pharma's recall involves their generic skin condition treatments, identified to have impurity problems, while Cipla is addressing contamination in an injection linked to particulate matter. These recalls align with the oversight of the U.S.